Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.
about
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.Immunoplasticity in cutaneous melanoma: beyond pure morphology.A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma.Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Oncolytic adenoviruses coated ...... and efficacy against melanoma.
@en
type
label
Oncolytic adenoviruses coated ...... and efficacy against melanoma.
@en
prefLabel
Oncolytic adenoviruses coated ...... and efficacy against melanoma.
@en
P2093
P2860
P50
P1433
P1476
Oncolytic adenoviruses coated ...... and efficacy against melanoma
@en
P2093
Andrea Vitale
Aniket Magarkar
Arto Urtti
Cristian Capasso
Mari Hirvinen
Marjo Yliperttula
Maxim Antopolsky
Teea Sarvela
Teemu Suutari
P2860
P304
P356
10.1080/2162402X.2015.1105429
P577
2015-10-29T00:00:00Z